DiepiserratenediolCAS# 3604-92-0 |
2D Structure
- 21-Episerratenediol
Catalog No.:BCN6253
CAS No.:1449-06-5
- Serratenediol
Catalog No.:BCN5061
CAS No.:2239-24-9
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 3604-92-0 | SDF | Download SDF |
PubChem ID | 21672659 | Appearance | Powder |
Formula | C30H50O2 | M.Wt | 442.72 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | CC1(C2CCC3(CC4=CCC5C(C(CCC5(C4CCC3C2(CCC1O)C)C)O)(C)C)C)C | ||
Standard InChIKey | FMUNNDDBCLRMSL-BMWRSPAGSA-N | ||
Standard InChI | InChI=1S/C30H50O2/c1-26(2)21-10-8-19-18-28(5)15-12-22-27(3,4)25(32)14-17-30(22,7)23(28)11-9-20(19)29(21,6)16-13-24(26)31/h8,20-25,31-32H,9-18H2,1-7H3/t20-,21-,22-,23-,24+,25+,28-,29+,30-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Diepiserratenediol has potential activity to inhibit tumor promotion, it shows potent inhibitory effects on EBV-EA induction (100% inhibition at 1000 mol ratio/TPA). |
Diepiserratenediol Dilution Calculator
Diepiserratenediol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.2588 mL | 11.2938 mL | 22.5876 mL | 45.1753 mL | 56.4691 mL |
5 mM | 0.4518 mL | 2.2588 mL | 4.5175 mL | 9.0351 mL | 11.2938 mL |
10 mM | 0.2259 mL | 1.1294 mL | 2.2588 mL | 4.5175 mL | 5.6469 mL |
50 mM | 0.0452 mL | 0.2259 mL | 0.4518 mL | 0.9035 mL | 1.1294 mL |
100 mM | 0.0226 mL | 0.1129 mL | 0.2259 mL | 0.4518 mL | 0.5647 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Ecdysone
Catalog No.:BCN2629
CAS No.:3604-87-3
- 2',4'-Dihydroxy-6'-methoxyacetophenone
Catalog No.:BCN5314
CAS No.:3602-54-8
- Nandrolone decanoate
Catalog No.:BCC9087
CAS No.:360-70-3
- Glycodeoxycholic acid
Catalog No.:BCN7250
CAS No.:360-65-6
- [Ala17]-MCH
Catalog No.:BCC6024
CAS No.:359784-84-2
- 3,6-Ditigloyloxynortropane
Catalog No.:BCN1877
CAS No.:359723-70-9
- Pterosin G
Catalog No.:BCN8148
CAS No.:35964-50-2
- Triptotin F
Catalog No.:BCN3482
CAS No.:359630-36-7
- Inotodiol
Catalog No.:BCN3331
CAS No.:35963-37-2
- 3-Acetoxy-11-ursen-28,13-olide
Catalog No.:BCN5313
CAS No.:35959-08-1
- 3-Hydroxy-11-ursen-28,13-olide
Catalog No.:BCN5312
CAS No.:35959-05-8
- Anchustrigosine
Catalog No.:BCC8185
CAS No.:
- Alpinetin
Catalog No.:BCN5315
CAS No.:36052-37-6
- Dihydrosanguinarine
Catalog No.:BCN3713
CAS No.:3606-45-9
- Tetrahydrocurcumin
Catalog No.:BCN2724
CAS No.:36062-04-1
- Hexahydrocurcumin
Catalog No.:BCN4641
CAS No.:36062-05-2
- Octahydrocurcumin
Catalog No.:BCN2725
CAS No.:36062-07-4
- B-HT 933 dihydrochloride
Catalog No.:BCC7474
CAS No.:36067-72-8
- B-HT 920
Catalog No.:BCC1417
CAS No.:36085-73-1
- Sodium cholate
Catalog No.:BCN6981
CAS No.:361-09-1
- Propranolol glycol
Catalog No.:BCC6817
CAS No.:36112-95-5
- RBC8
Catalog No.:BCC5569
CAS No.:361185-42-4
- 3,4-Secolupa-4(23),20(29)-diene-3,28-dioic acid
Catalog No.:BCN7243
CAS No.:36138-41-7
- Saxagliptin
Catalog No.:BCC3934
CAS No.:361442-04-8
Cancer chemopreventive activity of 3beta-methoxyserrat-14-en-21beta-ol and several serratane analogs on two-stage mouse skin carcinogenesis.[Pubmed:15363540]
Cancer Lett. 2004 Oct 28;214(2):149-56.
3beta-Methoxyserrat-14-en-21beta-ol (1) and 3alpha-methoxyserrat-14-en-21beta-ol (2) are the most abundant triterpenoids from two Picea plants, Picea jezoensis (Sieb. et Zucc.) Carr. var. jezoensis and P. jezoensis (Sieb. et Zucc.) Carr. hondoensis (Mayr) Rehder, and the total yield of 1 and 2 reach over 1/3 of the chloroform extract of the above two plants. This study deals with the potential of anti-tumor promoting activity of 1 and results of the assay of 22 synthetic serratane-type triterpenoids (6)-(27) derived from 1, 2, 21-episerratenediol (3), Diepiserratenediol (4) and 13alpha,14alpha-epoxy-3beta-methoxyserratan-21beta-ol (5) to discuss the structure-activity relationship. As a preliminary evaluation of their potential to inhibit tumor promotion, the inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) were used. All compounds except for 12 and 19 showed potent inhibitory effects on EBV-EA induction (100% inhibition at 1000 mol ratio/TPA), their effects being stronger than that of a positive control oleanolic acid. Compounds 1, 13, 14, 18, 20 and 26 were selected to examine the effect on the in vivo two-stage mouse skin carcinogenesis test induced by 7,12-dimethylbenz[a]anthracene (DMBA) as an initiator and TPA as a promoter. The most abundant triterpenoid 1 and the synthetic compounds 13 and 14 were found to exhibit the excellent anti-tumor promoting activity in the in vivo carcinogenesis test, and compounds 18, 20 and 26 also showed strong inhibitory effects.